​SWAN announces follow-on investment in Hubly Surgical

SWAN is pleased to announce follow-on funding in Hubly Surgical, which recently raised $3 million in an oversubscribed Funding Round.

In May 2023, Hubly Surgical announced that HUBLY DRILL, the first and only single-use cranial drill with advanced features for safety and efficiency in any setting, is FDA-cleared and now available for sale. Read more HERE.

Following FDA Clearance, this investment comes primarily from the Hubly commission-only distributor sales force, pre-existing investors, and the neurosurgeons and physicians who share the company’s vision.

SWAN previously invested in Hubly in 2021.